Form D · Biotechnology
EndoMetabolic Solutions, Inc.
Brooklyn Park, MN · CIK 0001456462
Offering snapshot reported Feb 17, 2009 · SEC filing
- Reported sold
- $3.83M Offering amount: $3.83M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2009 | Initial | $3,826,650 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-126966
Source: Form D, filed Feb 17, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David J. Blaeser | Director, Executive |
| Michel Gagner | Director, Executive |
| Peter Mc Nerney | Director |
| Dale A. Spencer | Director, Executive |
| Kathy Tune | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10813 Major Avenue North
Brooklyn Park, MN, 55443
Brooklyn Park, MN, 55443